Bank of America Corp. Reports 15% Ownership in Aptevo Therapeutics Inc.

Bank of America Corporation has filed a Schedule 13G with the SEC, disclosing a 15% ownership stake in Aptevo Therapeutics Inc. The filing indicates that Bank of America, along with its wholly owned subsidiaries BofA Securities, Inc. and Bank of America N.A., beneficially owns 494,341 shares of Aptevo's common stock. The shares are held in the ordinary course of business and not for the purpose of influencing the control of the issuer. The filing was made pursuant to Rule 13d-1(b) and was signed by an authorized signatory on October 6, 2025.